Research on Measuring the Return From Pharmaceutical Innovation
While M&A has been continuing since 2013, the pharmaceutical industry is facing multiple downward trends as shown in the infographic prepared by Deloitte Consulting. One silver lining is that they found smaller biopharma companies outperformed larger ones. Smaller firms more able to leverage technology to enhance their agility.
To learn more about the developing trends about cloud for pharmaceutical companies, request information.
You Might Also Like: